Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
283
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

789
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
789

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Tuberculosis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same author

Tuberculosis in Poland in 2021.

Przeglad epidemiologiczny·2024
Same author

Inventory study on completeness of tuberculosis case notifications in Poland in 2018.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024
Same author

Tuberculosis incidence in foreign-born people residing in European countries in 2020.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2023
Same author

Cladribine treatment in patients with pulmonary Langerhans cell histiocytosis.

Polish archives of internal medicine·2023
Same author

The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study.

Frontiers in public health·2023

相关实验视频

Updated: May 21, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K

在2022年波兰的结核病.

Maria Joanna Korzeniewska-Koseła1, Stefan Wesołowski2

  • 1Zakład Epidemiologii i Organizacji Walki z Gruźlicą, Instytut Gruźlicy i Chorób Płuc, Warszawa.

Przeglad epidemiologiczny
|March 18, 2025
PubMed
概括

波兰的结核病发病率在2022年增加了17.5%,男性和老年人的发病率更高. 波兰比欧盟/欧洲经济区国家显示出更好的细菌学确认和较低的多药耐药结核病率.

科学领域:

  • 流行病学 流行病学
  • 公共卫生 公共卫生
  • 传染性疾病 传染性疾病

背景情况:

  • 结核病 (TB) 仍然是一个重大的全球卫生挑战.
  • 了解当前的结核病流行病学对于有效的控制策略至关重要.

研究的目的:

  • 分析波兰2022年结核病流行病学情况.
  • 将波兰的结核病数据与欧盟和欧洲经济区 (EU/EEA) 国家的结核病数据进行比较.

主要方法:

  • 对2022年波兰注册结核病例的分析.
  • 包括药物敏感性结果和死亡率数据.
  • 与欧洲疾病预防和控制中心 (ECDC) 报告进行比较.

主要成果:

  • 波兰在2022年登记了4314例结核病例 (每10万人口中有11.4例),比2021年增加了17.5%.
  • 细菌学确认率为81.9%,高于欧盟/欧洲经济区平均水平 (70.6%).
  • 与欧盟/欧洲经济区 (4.4%) 相比,波兰的多抗药结核病 (MDR-TB) 率较低 (3.1%).

结论:

  • 波兰的结核病发病率正在上升,特别是在老年男性中.
关键词:
结核病通过培养得到证实.结核病发病率 结核病发生率药物耐药性 耐药性 药物耐药性格鲁兹利卡石是土壤中的一种.没有购买的性质.确认细菌学的情况.结核病 (TB) 是一种疾病.这就是Zapadalność的意义.

更多相关视频

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K

相关实验视频

Last Updated: May 21, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K
  • 与欧盟/欧洲经济区相比,波兰在结核病例确认和较低的MDR-TB率方面表现出强势.
  • 关于艾滋病毒同时感染和治疗结果的数据缺口需要注意全面的结核病控制.